Sequence requirements in the reactive-center loop of plasminogen-activator inhibitor-1 for recognition of plasminogen activators

European Journal of Biochemistry

Volumn 237, Issue 1, 1996, Pages 180-187

  Tucker, H Michael ^a   Gerard, Robert D ^a,b  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Mutagenesis; Plasminogen activator inhibitor; Rate constant; Serpin; Specificity

Indexed keywords

HYBRID PROTEIN; PLASMIN; PLASMINOGEN ACTIVATOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; SERINE PROTEINASE; SERINE PROTEINASE INHIBITOR; THROMBIN; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

AMINO ACID SUBSTITUTION; ARTICLE; CONTROLLED STUDY; DRUG SPECIFICITY; ENZYME INHIBITION; ESCHERICHIA COLI; GENE EXPRESSION; HUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; SITE DIRECTED MUTAGENESIS; STRUCTURE ACTIVITY RELATION;

ESCHERICHIA COLI;

EID: 0029875848     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1432-1033.1996.0180n.x     Document Type: Article

References (32)

1. Adams, D. S., Griffin, L. A., Nachajko, W. R., Reddy, V. B. & Wei, C. M. (1991) A synthetic DNA encoding a modified human urokinase resistant to inhibition by serum plasminogen activator inhibitor, J. Biol. Chem. 266, 8476-8482.
2. Beatty, K., Bieth, J. & Travis, J. (1980) Kinetics of association of serine proteinases with native and oxidized alpha-1-proteinase inhibitor and alpha-1-antichymotrypsin, J. Biol. Chem. 255, 3931-3934.
3. Bode, W., Mayr, I., Baumann, U., Huber, R., Stone, S. R. & Hofsteenge, J. (1989) The refined 1.9 Å crystal structure of human alpha-thrombin: interaction with D-Phe-Pro-Arg chloromethylketone and significance of the Tyr-Pro-Pro-Trp insertion segment. EMBO J. 8, 3467-3475.
4. Carrell, R. & Travis, J. (1985) α1-antitrypsin and the serpins:variation and countervariation. Trends Biochem. Sci. 10, 20-24.
5. Carrell, R. W., Pemberton, P. A. & Boswell, D. R. (1987) The serpins: evolution and adaptation in a family of protease inhibitors, Cold Spring Harbor Symp. Quant. Biol. 52, 527-535.
6. Carrell, R. W., Stein, P. E., Fermi, G. & Wardell, M. (1994) Biological implications of a 3 Å structure of dimeric antithrombin, Structure 2, 257-270.
7. Ehrlich, H. J., Gebbink, R. K., Keijer, J., Linders, M., Preissner, K. T. & Pannekoek, H. (1990) Alteration of serpin specificity by a protein cofactor, J. Biol. Chem. 265, 13 029-13 035.
8. Franke, A. E., Danley, D. E., Kaczmarek, F. S., Hawrylik, S. J., Gerard, R. D., Lee, S. E. & Geoghegan, K. F. (1990) Expression of human plasminogen activator inhibitor type-1 (PAI-1) in Escherichia coli as a soluble protein comprised of active and latent forms. Isolation and crystallization of latent PAI-1. Biochim. Biophys. Acta 1017, 16-23.
9. Hekman, C. M. & Loskutoff, D. J. (1988) Kinetic analysis of the interactions between plasminogen activator inhibitor 1 and both urokinase and tissue plasminogen activator, Arch. Biochem. Biophys. 262, 199-210.
10. Hermans, J. M. & Stone, S. R. (1993) Interaction of activated protein C with serpins, Biochem. J. 295, 239-245.
11. Horrevoets, A. J. G., Tans, G., Smilde, A. E., Zonneveld, A. J. & Pannekeok, H. (1994) Thrombin-variable region 1 (VR1). Evidence for the dominant contribution of VR1 of serine proteases to their interaction with plasminogen activator inhibitor 1, J. Biol. Chem. 268, 779-782.
12. Huber, R. & Carrell, R. W. (1989) Implications of the three dimensional structure of α1-antitrypsin for structure and function of serpins, Biochemistry 28, 8951-8966.
13. Keijer, J., Linders, M., Wegman, J. J., Ehrlich, H. J., Mertens, K. & Pannekoek, H. (1991) On the target specificity of plasminogen activator inhibitor 1: the role of heparin, vitronectin, and the reactive site, Blood 78, 1254-1261.
14. Laskowski, M. & Kato, I. (1980) Protein inhibitors of proteinases, Annu. Rev. Biochem. 49, 593-626.
15. Lawrence, D. A., Strandberg, L., Ericson, J. & Ny, T. (1990) Structure-function studies of the serpin plasminogen activator inhibitor type 1: analysis of chimeric strained loop mutants, J. Biol. Chem. 265, 20 293-20 301.
16. Loebermann, H., Tokuoka, R., Deisenhofer, J. & Huber, R. (1984) Human α1-proteinase inhibitor, J. Mol. Biol. 177, 531-557.
17. Madison, E. L., Goldsmith, E. J., Gerard, R. D., Gething, M. J. & Sambrook, J. F. (1989) Serpin-resistant mutants of human tissue-type plasminogen activator, Nature 339, 721-724.
18. Madison, E. L., Goldsmith, E. J., Gerard, R. D., Gething, M. J., Sambrook, J. F. & Bassel-Duby, R. S. (1990a) Amino acid residues that affect interaction of tissue-type plasminogen activator with plasminogen activator inhibitor 1, Proc. Natl Acad. Sci. USA 87, 3530-3533.
19. Madison, E. L., Goldsmith, E. J., Gething, M. J., Sambrook, J. F. & Gerard, R. D. (1990b) Restoration of serine protease:inhibitor interaction by protein engineering, J. Biol. Chem. 265, 21 423-21 426.
20. Mottonen, J., Strand, A., Symersky, J., Sweet, R. M., Danley, D. E., Geoghegan, K. F., Gerard, R. D. & Goldsmith, E. J. (1992) Structural basis of latency in plasminogen activator inhibitor-1, Nature 355, 270-273.
21. Phillips, J. E., Cooper, S. T., Potter, E. E. & Church, F. C. (1994) Mutagenesis of recombinant protein C inhibitor reactive site residues alters target proteinase specificity, J. Biol. Chem. 269, 16 696-16 700.
22. Sambrook, J., Fritsch, E. F. & Maniatis, T. (1989) Molecular cloning: a laboratory manual, 2nd edn, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
23. Schreuder, H. A., de Boer, B. B., Dijkema, R., Mulders, J., Theunissen, H. J. M., Grootenhuis, P. D. J. & Hol, W. G. J. (1994) Intact and cleaved human antithrombin III complex as a model for serpin-proteinase interactions, Nature Struct. Biol. 1, 48-54.
24. Sherman, P. M., Lawrence, D. A., Yang, A. Y., Vandenberg, E. T., Paielle, D., Olson, S. T., Shore, J. D. & Ginsburg, D. (1992) Saturation mutagenesis of the plasminogen activator inhibitor-1 reactive center, J. Biol. Chem. 267, 1-8.
25. Shubeita, H. E., Cottey, T. L., Franke, A. E. & Gerard, R. D. (1990) Mutational and immunochemical analysis of plasminogen activator inhibitor-1, J. Biol. Chem. 265, 18 379-18 385.
26. Stein, P. E., Leslie, A. G. W., Finch, J. T., Turnell, W. G., McLaughlin, P. J. & Carrell, R. W. (1990) Crystal structure of ovalbumin as a model for the reactive center of serpins, Nature 347, 99-102.
27. Testa, J. E., Stefansson, S., Sioussat, S. & Quigley, J. P. (1995) Avian urokinase-type plasminogen activator (u-PA) lacks the putative binding site for plasminogen activator inhibitor (PAI) and is resistant to inhibition by human PAI-1 and PAI-2, Fibrinolysis 9, 93-99.
28. Thorsen, S., Philips, M., Selmer, J., Lecander, I. & Astedt, B. (1988) Kinetics of inhibition of tissue-type and urokinase type plasminogen activator by plasminogen activator inhibitor type 1 and type 2, Eur. J. Biochem. 175, 33-39.
29. Wei, A., Rubin, H., Cooperman, B. S. & Christianson, D. W. (1994) Crystal structure of an uncleaved serpin reveals the conformation of an inhibitory reactive loop, Nature Struct. Biol. 1, 251-258.
30. Wiman, B. & Collen, D. (1978) On the kinetics of reaction between human antiplasmin and plasmin, Eur. J. Biochem. 84, 573-578.
31. Wright, H. T., Qian, H. X. & Huber, R. (1990) Crystal structure of plakalbumin, a proteolytically nicked form of ovalbumin. Its relationship to the structure of cleaved alpha-1-proteinase inhibitor, J. Mol. Biol. 213, 513-528.
32. York, J. D., Ping, L. & Gardell, S. J. (1991) Combinatorial mutagenesis of the reactive site region in plasminogen activator inhibitor I, J. Biol. Chem. 266, 8495-8500.